NO982570L - Benzofurankarboksamider og -sulfonamider - Google Patents
Benzofurankarboksamider og -sulfonamiderInfo
- Publication number
- NO982570L NO982570L NO982570A NO982570A NO982570L NO 982570 L NO982570 L NO 982570L NO 982570 A NO982570 A NO 982570A NO 982570 A NO982570 A NO 982570A NO 982570 L NO982570 L NO 982570L
- Authority
- NO
- Norway
- Prior art keywords
- sulfonamides
- benzofuran
- benzofuran carboxamides
- carboxamides
- carboxides
- Prior art date
Links
- 150000003456 sulfonamides Chemical class 0.000 title abstract 2
- QHKJIJXBJCOABP-UHFFFAOYSA-N 1-benzofuran-2-carboxamide Chemical class C1=CC=C2OC(C(=O)N)=CC2=C1 QHKJIJXBJCOABP-UHFFFAOYSA-N 0.000 title 1
- 229940124530 sulfonamide Drugs 0.000 title 1
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 102000003390 tumor necrosis factor Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9524832.4A GB9524832D0 (en) | 1995-12-05 | 1995-12-05 | Novel compounds |
| GBGB9610515.0A GB9610515D0 (en) | 1996-05-20 | 1996-05-20 | Novel compounds |
| GBGB9610712.3A GB9610712D0 (en) | 1995-12-05 | 1996-05-22 | Novel compounds |
| PCT/GB1996/003012 WO1997020833A1 (en) | 1995-12-05 | 1996-12-05 | Benzofuran carboxamides and sulphonamides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO982570D0 NO982570D0 (no) | 1998-06-04 |
| NO982570L true NO982570L (no) | 1998-08-04 |
Family
ID=27268015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO982570A NO982570L (no) | 1995-12-05 | 1998-06-04 | Benzofurankarboksamider og -sulfonamider |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5773467A (es) |
| EP (1) | EP0873331B1 (es) |
| JP (1) | JP2000501411A (es) |
| KR (1) | KR19990071894A (es) |
| CN (1) | CN1100773C (es) |
| AT (1) | ATE215540T1 (es) |
| AU (1) | AU697976B2 (es) |
| BR (1) | BR9611897A (es) |
| CA (1) | CA2238376C (es) |
| CZ (1) | CZ292443B6 (es) |
| DE (1) | DE69620458T2 (es) |
| ES (1) | ES2172695T3 (es) |
| HU (1) | HUP9903797A3 (es) |
| NO (1) | NO982570L (es) |
| PL (1) | PL327181A1 (es) |
| WO (1) | WO1997020833A1 (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR199802386T2 (xx) * | 1996-05-20 | 1999-02-22 | Darwin Discovery Limited | Benzofuran karboksamidler ve bunlar�n terap�tik kullan�m�. |
| ATE229516T1 (de) * | 1996-08-19 | 2002-12-15 | Altana Pharma Ag | Benzofuran-4-carboxamide |
| JP3268236B2 (ja) | 1997-07-22 | 2002-03-25 | シャープ株式会社 | 電子写真感光体、及びビスヒドラゾン化合物およびその中間体、ならびにそれら化合物の製造方法 |
| JP4219554B2 (ja) * | 1997-10-01 | 2009-02-04 | 協和発酵キリン株式会社 | ベンゾフラン誘導体 |
| AU1983599A (en) * | 1998-01-26 | 1999-08-09 | Kyowa Hakko Kogyo Co. Ltd. | Oxygenic heterocyclic compounds |
| CA2317478A1 (en) * | 1998-02-09 | 1999-08-12 | Darwin Discovery Limited | Benzofuran-4-carboxamides and their therapeutic use |
| FR2778662B1 (fr) * | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| TW555759B (en) * | 1998-06-08 | 2003-10-01 | Darwin Discovery Ltd | Heterocyclic compounds and their therapeutic use |
| US6303789B1 (en) * | 1998-06-10 | 2001-10-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| CA2715683A1 (en) | 1999-08-21 | 2001-03-01 | Nycomed Gmbh | Synergistic combination |
| US7217722B2 (en) | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| GB0011802D0 (en) * | 2000-05-16 | 2000-07-05 | Smithkline Beecham | Method for enhancing cognitive function |
| EA200501548A1 (ru) | 2003-04-01 | 2006-02-24 | Апплайд Резеч Системз Арс Холдинг Н.В. | Ингибиторы фосфодиэстераз при бесплодии |
| FR2903106B1 (fr) * | 2006-07-03 | 2010-07-30 | Sanofi Aventis | Utilisations de 2-benzoyl-imidazopyridines en therapeutique |
| EP2196465A1 (en) | 2008-12-15 | 2010-06-16 | Almirall, S.A. | (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors |
| AR074760A1 (es) * | 2008-12-18 | 2011-02-09 | Metabolex Inc | Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico. |
| EP2226323A1 (en) | 2009-02-27 | 2010-09-08 | Almirall, S.A. | New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives |
| EP2380890A1 (en) | 2010-04-23 | 2011-10-26 | Almirall, S.A. | New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors |
| EP2394998A1 (en) | 2010-05-31 | 2011-12-14 | Almirall, S.A. | 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors |
| EP2597093B1 (en) | 2010-07-22 | 2014-11-05 | Fuso Pharmaceutical Industries, Ltd. | Benzofuranone compound and pharmaceutical composition containing same |
| WO2016112036A1 (en) | 2015-01-05 | 2016-07-14 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Myc g-quadruplex stabilizing small molecules and their use |
| CN114149457B (zh) * | 2021-11-03 | 2024-04-12 | 湖北民族大学 | 一种苯并[c][1,2]氧杂硼戊环-1(3H)-醇类合物及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1260947A (en) * | 1984-12-29 | 1989-09-26 | Yoshitaka Ohishi | Benzofuran derivative, process for preparing the same and pharmaceutical composition containing the same |
| DK0685475T3 (da) * | 1994-05-31 | 1999-08-30 | Bayer Ag | Amino-benzofuryl- og thienylderivater |
| NZ290420A (en) * | 1994-07-22 | 1999-01-28 | Byk Gulden Lomberg Chem Fab | Phenyl or pyridyl-amide substituted dihydro benzofurans; medicaments |
| AU705690B2 (en) * | 1995-05-19 | 1999-05-27 | Kyowa Hakko Kogyo Co. Ltd. | Oxygen-containing heterocyclic compounds |
| TR199802386T2 (xx) * | 1996-05-20 | 1999-02-22 | Darwin Discovery Limited | Benzofuran karboksamidler ve bunlar�n terap�tik kullan�m�. |
-
1996
- 1996-12-05 CN CN96198844A patent/CN1100773C/zh not_active Expired - Fee Related
- 1996-12-05 BR BR9611897-0A patent/BR9611897A/pt active Search and Examination
- 1996-12-05 EP EP96941138A patent/EP0873331B1/en not_active Expired - Lifetime
- 1996-12-05 CA CA002238376A patent/CA2238376C/en not_active Expired - Fee Related
- 1996-12-05 PL PL96327181A patent/PL327181A1/xx unknown
- 1996-12-05 US US08/761,102 patent/US5773467A/en not_active Expired - Fee Related
- 1996-12-05 ES ES96941138T patent/ES2172695T3/es not_active Expired - Lifetime
- 1996-12-05 CZ CZ19981714A patent/CZ292443B6/cs not_active IP Right Cessation
- 1996-12-05 AU AU10386/97A patent/AU697976B2/en not_active Ceased
- 1996-12-05 HU HU9903797A patent/HUP9903797A3/hu unknown
- 1996-12-05 JP JP9521090A patent/JP2000501411A/ja not_active Ceased
- 1996-12-05 KR KR1019980704179A patent/KR19990071894A/ko not_active Ceased
- 1996-12-05 AT AT96941138T patent/ATE215540T1/de not_active IP Right Cessation
- 1996-12-05 DE DE69620458T patent/DE69620458T2/de not_active Expired - Fee Related
- 1996-12-05 WO PCT/GB1996/003012 patent/WO1997020833A1/en not_active Ceased
-
1998
- 1998-06-04 NO NO982570A patent/NO982570L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2238376A1 (en) | 1997-06-12 |
| MX9804466A (es) | 1998-12-31 |
| AU1038697A (en) | 1997-06-27 |
| CN1208411A (zh) | 1999-02-17 |
| PL327181A1 (en) | 1998-11-23 |
| BR9611897A (pt) | 1999-12-28 |
| WO1997020833A1 (en) | 1997-06-12 |
| ES2172695T3 (es) | 2002-10-01 |
| ATE215540T1 (de) | 2002-04-15 |
| US5773467A (en) | 1998-06-30 |
| CZ171498A3 (cs) | 1998-10-14 |
| DE69620458D1 (de) | 2002-05-08 |
| EP0873331B1 (en) | 2002-04-03 |
| CN1100773C (zh) | 2003-02-05 |
| HUP9903797A2 (hu) | 2001-04-28 |
| EP0873331A1 (en) | 1998-10-28 |
| AU697976B2 (en) | 1998-10-22 |
| NO982570D0 (no) | 1998-06-04 |
| CZ292443B6 (cs) | 2003-09-17 |
| HUP9903797A3 (en) | 2001-08-28 |
| JP2000501411A (ja) | 2000-02-08 |
| CA2238376C (en) | 2006-08-15 |
| DE69620458T2 (de) | 2002-10-02 |
| KR19990071894A (ko) | 1999-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE215540T1 (de) | Benzofuran-carboxamide und -sulfonamide | |
| DE59709414D1 (de) | Oxyiminopregnancarbolactone | |
| ATE227587T1 (de) | Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts | |
| ATE251140T1 (de) | N-(2 oxoacetyl oder sulphonyl)- pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität | |
| TR199701490A2 (xx) | 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�. | |
| TR200000755T2 (tr) | Karşıt olma-karşı gelme bozukluğunun tedavisi. | |
| DE69034070D1 (de) | Racemisches Huperzin A | |
| DE69713300D1 (de) | Benzopyran derivate mit leukotrien-antagonistischer wirkung | |
| DK0637306T3 (da) | 4-Imidomethyl-1-[2'-phenyl-2'-oxoethyl]-piperidiner som serotonin-5HT2-antagonister, deres fremstilling og anvendelse til terapi | |
| DE69732036D1 (de) | Verwendung von aryl-n-substituierten carboxamiden zum töten von tumoren | |
| DK1242410T3 (da) | Nye forbindelser | |
| BG50159A3 (bg) | Метод за получаване на производни на пиранобензоксадиазол | |
| ES2068714T3 (es) | Derivados de pirimidina para aumentar la actividad antitumoral. | |
| SE9802209D0 (sv) | Novel compounds | |
| MX9202366A (es) | Nuevas 2-amino-5-ciano-1,4-di hidro piridinas y procedimiento para su fabricacion. | |
| AU2002223731A1 (en) | Anti-inflammatory and healing medicine based on laminarin sulphate | |
| RU96104062A (ru) | Средство "витадерм" в комплексной терапии ожоговых ран | |
| RU94024337A (ru) | Антиметастатическое средство | |
| RU92007680A (ru) | Средство, обладающее тонизирующим действием на гладкую мускулатуру вен, мочевого пузыря и предстательной железы | |
| JPS533593A (en) | Preparation of gel-forming microbial protein | |
| FI965171L (fi) | Oksatsofosforiinien, esimerkiksi ifosfamidin, enantiomeerien käyttö kasvainten hoidossa sivuvaikutuksien vähentämiseksi | |
| SE9802207D0 (sv) | Novel compounds | |
| ES2181160T3 (es) | Derivados de 1,4-dihidropiridina y su utilizacion en terapia. | |
| DE69210737D1 (de) | Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen | |
| EP1714661A3 (en) | Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |